Adding Cetuximab to Paclitaxel and Carboplatin for First-Line Treatment of Carcinoma of Unknown Primary
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adding Cetuximab to Paclitaxel and Carboplatin for First-Line Treatment of Carcinoma of Unknown Primary (CUP): Results of the Phase 2 AIO Trial PACET-CUP
Br. J. Cancer 2020 Nov 25;[EPub Ahead of Print], G Folprecht, K Trautmann, A Stein, G Huebner, M Stahl, S Kasper, A Kretzschmar, CH Köhne, V Grünwald, RD Hofheinz, K Schütte, H Löffler, C Bokemeyer, A KrämerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.